GLP-1 비만 신약에 ‘오남용’ 꼬리표 붙나…식약처 의견수렴 마감, 의료계 “치료 위축 우려” (opens original article in a new tab)

No comments yet

Threaded discussion is coming next — this is where the community conversation about this story will live.